Annual Report FY26: Loss Widens to Rs 111L, Zero Revenue, Name Change Proposed

Pat NegativeResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.5%Reaction day

₹7.44

prior close

₹7.80

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.6%+0.1% vs market

Commodity Chemicals peers, median of 61sector+0.5%-1.1% vs sector

On the reaction day the stock moved 0.1 pts more than Nifty Microcap 250 and 1.1 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

-2.8

30m

-1.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.5-0.6+0.1+0.5-1.1

Next day

+0.3+0.0+0.3+1.2-1.0

-1.7+0.7-2.4+0.8-2.5

+1.9+1.1+0.8+1.2+0.7

+2.7+1.6+1.1+2.1+0.6

+3.5+1.5+2.0+1.3+2.2

+8.9+1.4+7.5+0.8+8.1

15d

+5.5+0.4+5.1+1.8+3.7

+6.2-1.4+7.6-1.2+7.4

—————

UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 61Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Gayatri BioOrganics submitted 35th Annual Report for FY26. Net loss widened to Rs 111.18L from Rs 72.65L, with no revenue for two straight years. Reserves negative at Rs 3700.49L, no dividend. AGM on Sept 23 via video conferencing, cut-off Sept 16. Resolutions: rename company to Ananth BioOrganics Limited and appoint Sreedhara Reddy Kanaparthi as Chairman and MD for 3 years.

Likely market impact

Widening losses, zero revenue, and negative reserves signal distress. Name change and new MD point to a strategic reset.